Charles River Laboratories (CRL) Tops Q3 EPS by 53c
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $232.51 -0.9%
EPS Growth %: -12.2%
Financial Fact:
Selling, general and administrative: 85.65M
Today's EPS Names:
HFBL, PBHC, PBNK, More
EPS Growth %: -12.2%
Financial Fact:
Selling, general and administrative: 85.65M
Today's EPS Names:
HFBL, PBHC, PBNK, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q3 EPS of $2.33, $0.53 better than the analyst estimate of $1.80. Revenue for the quarter came in at $743.3 million versus the consensus estimate of $716.36 million.
GUIDANCE:
Charles River Laboratories sees FY2020 EPS of $7.75-$7.85, versus the consensus of $7.26.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- inTEST Corp (INTT) reported Q2 Revenue ; Offers Guidance
- Regency Centers (REG) Tops Q2 EPS by 2c
- Arbor Realty Trust (ABR) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
